ABVC BioPharma, Inc.'s market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; ABVC BioPharma, Inc. is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 15.88K	$ 6.11K	$ 128.27K	$ 588.99K	$ 42.27K
Gross Profit	$ -13.73K	$ -66.87K	$ 68.04K	$ 323.58K	$ 31.53K
EBIT	$ -2.15M	$ -2.12M	$ -1.89M	$ -3.55M	$ -3.65M
EBITDA	-	$ -2.11M	$ -1.89M	$ -3.55M	$ -3.64M
Net Income Common Stockholders	$ -3.32M	$ -2.26M	$ 2.10M	$ -4.86M	$ -3.70M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 568.59K	$ 818.98K	$ 1.87M	$ 1.47M	$ 1.40M
Total Assets	$ 16.59M	$ 9.32M	$ 10.73M	$ 9.86M	$ 10.48M
Total Debt	$ 3.41M	$ 5.18M	$ 5.21M	$ 3.05M	$ 3.11M
Net Debt	$ 2.84M	$ 4.36M	$ 3.34M	$ 1.59M	$ 1.71M
Total Liabilities	$ 7.53M	$ 9.69M	$ 9.00M	$ 6.62M	$ 4.79M
Stockholders Equity	$ 9.10M	$ -379.31K	$ 1.67M	$ 3.10M	$ 5.92M
Cash Flow	-
Free Cash Flow	-	$ -1.34M	$ -1.50M	$ -461.16K	$ -518.06K
Operating Cash Flow	$ -1.36M	$ -899.83K	$ -1.50M	$ -461.07K	$ -513.70K
Investing Cash Flow	$ -73.78K	$ -440.57K	-	$ -83.29K	$ -1.52M
Financing Cash Flow	$ 1.66M	$ -31.59K	$ 2.21M	$ -253.50K	$ 603.50K

Currency in USD

ABVC BioPharma, Inc. Earnings and Revenue History

Income Statement >

ABVC BioPharma, Inc. Debt to Assets

Balance Sheet >

ABVC BioPharma, Inc. Cash Flow

Cash Flow >

ABVC BioPharma, Inc. Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing